Vaccinex announces 1-for-15 reverse stock split

Vaccinex announced that it will effect a 1-for-15 reverse stock split of its issued common stock, effective at 5:00 p.m. Eastern Time on Monday, September 25. Beginning Tuesday, September 26, the company’s common stock will trade on a split-adjusted basis. The company’s Board of Directors implemented the reverse stock split with the objective of regaining compliance with the $1.00 minimum bid price requirement of The Nasdaq Capital Market. The company has until October 9 to comply with this requirement. To evidence compliance with this requirement, the closing bid price of the company’s common stock must be at least $1.00 per share for a minimum of 10 consecutive business days by October 9. The company’s shares of common stock will continue to trade on The Nasdaq Capital Market under the symbol “VCNX.” The new CUSIP number for the company’s common stock post-reverse stock split is 918640202.